Home › Companies › MACROGENICS INC. › 2024-2025

MACROGENICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and MACROGENICS INC.’s Form 8-K, filed 2025-05-22 (Item 5.07 on EDGAR). Page generated 02 October 2026.

7Reported items
143Asset managers
1,106Fund votes
2025-05-21Meeting date

Proxy season: 2023-2024 2024-2025

Explore MACROGENICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by MACROGENICS INC.

These tallies are MACROGENICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-22 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

MACROGENICS INC. — official shareholder meeting results, meeting held 2025-05-21
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Karen Ferrante, M.D.	43,243,033	--	--	590,255	8,171,555	Majority: yes
Elect Director: William Heiden	43,142,373	--	--	690,915	8,171,555	Majority: yes
Elect Director: Edward Hurwitz	42,988,515	--	--	844,773	8,171,555	Majority: yes
Elect Director: Meenu Chhabra Karson	43,279,299	--	--	553,989	8,171,555	Majority: yes
Proposal 2: approved. The voting results were as follows:	51,349,901	590,396	64,546	--	--	Majority: yes
Proposal 3 . To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.	42,433,276	1,382,356	17,656	--	8,171,555	Majority: yes
Proposal 4 . To approve an amendment to the MacroGenics, Inc.	26,266,489	17,556,578	10,221	--	8,171,555	Majority: yes

Source: MACROGENICS INC., Form 8-K, filed with the SEC on 2025-05-22 — read the filing on EDGAR.

How asset managers voted at the MACROGENICS INC. 2024-2025 meeting

Each item below shows how the 143 asset managers that disclosed a MACROGENICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of MACROGENICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 42,433,276AGAINST: 1,382,356

MACROGENICS INC.’s own tally for this item (“Proposal 3 . To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.”): 42,433,276 for, 1,382,356 against, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,090,323 outstanding shares: 67% for, 2% against (69% of the company cast a for/against vote).

The 142 asset managers below cast 97% of the shares they voted on this item FOR (37,649,138 for, 1,033,042 against).

FOR 97%

FOR: 37,649,138 (97.3%)AGAINST: 1,033,042 (2.7%)NOT VOTED: 400 (0.0%)

Largest asset managers voting on “To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in t” at MACROGENICS INC., 2024-2025
Asset manager	For	Against	Vote
ARMISTICE CAPITAL, LLC	5,485,872	0	For
Vanguard	4,458,555	0	For
BlackRock	4,452,882	0	For
WASATCH ADVISORS LP	3,838,540	0	For
WASATCH FUNDS TRUST	3,576,558	0	For
Frazier Life Sciences Management, L.P.	3,175,665	0	For
Fidelity	1,466,316	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,453,453	0	For
Rock Springs Capital Management LP	1,054,147	0	For
Charles Schwab	1,048,564	0	For
State Street	890,265	0	For
JACOBS LEVY EQUITY MANAGEMENT, INC	606,617	0	For
Dimensional	0	518,418	Against
Two Sigma	488,407	0	For
Delaware/Macquarie	420,000	0	For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	420,000	0	For
PINNACLE ASSOCIATES LTD	369,971	0	For
Northern Trust	354,952	0	For
Renaissance	347,351	0	For
MARSHALL WACE, LLP	339,299	0	For
Connor, Clark & Lunn Investment Management Ltd.	338,404	0	For
Vestal Point Capital, LP	235,200	0	For
Amundi	0	214,278	Against
Equitable	210,850	0	For
STRS OHIO	207,200	0	For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

2. To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Edward Hurwitz

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 42,988,515WITHHELD: 844,773

MACROGENICS INC.’s own tally for this item (“Elect Director: Edward Hurwitz”): 42,988,515 for, 844,773 withheld, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,090,323 outstanding shares: 68% for, 1% withheld (69% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (14,482,759 for, 0 against).

FOR 99.0%

FOR: 14,482,759 (99.1%)ABSTAIN: 133,436 (0.9%)

Largest asset managers voting on “To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting o” at MACROGENICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	4,345,235	0	For
WASATCH FUNDS TRUST	3,576,558	0	For
BlackRock	2,585,492	0	For
Fidelity	1,356,873	0	For
Charles Schwab	524,282	0	For
Dimensional	434,316	0	For
Delaware/Macquarie	420,000	0	For
Equitable	108,120	102,730	For
TIAA	195,772	0	For
BRIDGEWAY FUNDS INC	125,000	0	For
QUANTITATIVE MASTER SERIES LLC	108,027	0	For
Voya	97,922	0	For
Lincoln Financial	52,863	0	For
CLEARWATER INVESTMENT TRUST	50,311	0	For
ETF Series Solutions	45,885	0	For
Nationwide	40,316	0	For
Columbia Threadneedle	40,225	0	For
American Century	37,009	0	For
Global X	36,499	0	For
Northern Trust	32,213	0	For
Goldman Sachs	31,208	0	For
Invesco	0	29,421	Abstain
John Hancock	23,853	0	For
Pacific Life	22,323	0	For
ALPS ETF Trust	21,449	0	For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

3. To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Karen Ferrante, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 43,243,033WITHHELD: 590,255

MACROGENICS INC.’s own tally for this item (“Elect Director: Karen Ferrante, M.D.”): 43,243,033 for, 590,255 withheld, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,090,323 outstanding shares: 69% for, 1.0% withheld (69% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (14,513,465 for, 0 against).

FOR 99.2%

FOR: 14,513,465 (99.3%)ABSTAIN: 102,730 (0.7%)

Largest asset managers voting on “To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting o” at MACROGENICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	4,345,235	0	For
WASATCH FUNDS TRUST	3,576,558	0	For
BlackRock	2,585,492	0	For
Fidelity	1,356,873	0	For
Charles Schwab	524,282	0	For
Dimensional	434,316	0	For
Delaware/Macquarie	420,000	0	For
Equitable	108,120	102,730	For
TIAA	195,772	0	For
BRIDGEWAY FUNDS INC	125,000	0	For
QUANTITATIVE MASTER SERIES LLC	108,027	0	For
Voya	97,922	0	For
Lincoln Financial	52,863	0	For
CLEARWATER INVESTMENT TRUST	50,311	0	For
ETF Series Solutions	45,885	0	For
Nationwide	40,316	0	For
Columbia Threadneedle	40,225	0	For
American Century	37,009	0	For
Global X	36,499	0	For
Northern Trust	32,213	0	For
Goldman Sachs	31,208	0	For
Invesco	29,421	0	For
John Hancock	23,853	0	For
Pacific Life	22,323	0	For
ALPS ETF Trust	21,449	0	For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

4. To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: Meenu Chhabra Karson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 43,279,299WITHHELD: 553,989

MACROGENICS INC.’s own tally for this item (“Elect Director: Meenu Chhabra Karson”): 43,279,299 for, 553,989 withheld, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,090,323 outstanding shares: 69% for, 0.9% withheld (69% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (14,512,180 for, 0 against).

FOR 99.2%

FOR: 14,512,180 (99.3%)ABSTAIN: 104,015 (0.7%)

Largest asset managers voting on “To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting o” at MACROGENICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	4,345,235	0	For
WASATCH FUNDS TRUST	3,576,558	0	For
BlackRock	2,585,492	0	For
Fidelity	1,356,873	0	For
Charles Schwab	524,282	0	For
Dimensional	434,316	0	For
Delaware/Macquarie	420,000	0	For
Equitable	108,120	102,730	For
TIAA	195,772	0	For
BRIDGEWAY FUNDS INC	125,000	0	For
QUANTITATIVE MASTER SERIES LLC	108,027	0	For
Voya	97,922	0	For
Lincoln Financial	52,863	0	For
CLEARWATER INVESTMENT TRUST	50,311	0	For
ETF Series Solutions	45,885	0	For
Nationwide	40,316	0	For
Columbia Threadneedle	40,225	0	For
American Century	37,009	0	For
Global X	36,499	0	For
Northern Trust	32,213	0	For
Goldman Sachs	31,208	0	For
Invesco	29,421	0	For
John Hancock	23,853	0	For
Pacific Life	22,323	0	For
ALPS ETF Trust	21,449	0	For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

5. To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their earlier death, resignation or removal: William Heiden

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 43,142,373WITHHELD: 690,915

MACROGENICS INC.’s own tally for this item (“Elect Director: William Heiden”): 43,142,373 for, 690,915 withheld, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,090,323 outstanding shares: 68% for, 1% withheld (69% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (14,505,880 for, 0 against).

FOR 99.2%

FOR: 14,505,880 (99.2%)ABSTAIN: 110,315 (0.8%)

Largest asset managers voting on “To elect four Class III directors listed in the proxy materials to hold office until the 2028 Annual Meeting o” at MACROGENICS INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	4,345,235	0	For
WASATCH FUNDS TRUST	3,576,558	0	For
BlackRock	2,585,492	0	For
Fidelity	1,356,873	0	For
Charles Schwab	524,282	0	For
Dimensional	434,316	0	For
Delaware/Macquarie	420,000	0	For
Equitable	108,120	102,730	For
TIAA	195,772	0	For
BRIDGEWAY FUNDS INC	125,000	0	For
QUANTITATIVE MASTER SERIES LLC	108,027	0	For
Voya	97,922	0	For
Lincoln Financial	52,863	0	For
CLEARWATER INVESTMENT TRUST	50,311	0	For
ETF Series Solutions	45,885	0	For
Nationwide	40,316	0	For
Columbia Threadneedle	40,225	0	For
American Century	37,009	0	For
Global X	36,499	0	For
Northern Trust	32,213	0	For
Goldman Sachs	31,208	0	For
Invesco	29,421	0	For
John Hancock	23,853	0	For
Pacific Life	22,323	0	For
ALPS ETF Trust	21,449	0	For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

6. To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials.

COMPENSATIONMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

60% Majority: yes · of votes cast

FOR 60%AGAINST 40%

FOR: 26,266,489AGAINST: 17,556,578

MACROGENICS INC.’s own tally for this item (“Proposal 4 . To approve an amendment to the MacroGenics, Inc.”): 26,266,489 for, 17,556,578 against, per its Form 8-K filed 2025-05-22 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 63,090,323 outstanding shares: 42% for, 28% against (69% of the company cast a for/against vote).

The 48 asset managers below cast 87% of the shares they voted on this item FOR (12,740,341 for, 1,863,878 against).

FOR 87%13%

FOR: 12,740,341 (87.2%)AGAINST: 1,863,878 (12.8%)

Largest asset managers voting on “To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materi” at MACROGENICS INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	4,345,235	0	For
WASATCH FUNDS TRUST	3,576,558	0	For
BlackRock	2,585,492	0	For
Fidelity	1,355,873	1,000	For
Charles Schwab	524,282	0	For
Dimensional	0	434,316	Against
Delaware/Macquarie	0	420,000	Against
Equitable	108,120	102,730	For
TIAA	0	195,772	Against
BRIDGEWAY FUNDS INC	0	125,000	Against
QUANTITATIVE MASTER SERIES LLC	108,027	0	For
Voya	0	97,922	Against
Lincoln Financial	0	52,863	Against
CLEARWATER INVESTMENT TRUST	0	50,311	Against
ETF Series Solutions	0	45,885	Against
Nationwide	14,915	25,401	Against
Columbia Threadneedle	0	40,225	Against
American Century	0	37,009	Against
Global X	36,499	0	For
Northern Trust	32,213	0	For
Goldman Sachs	0	31,208	Against
Invesco	0	29,421	Against
John Hancock	0	23,853	Against
Pacific Life	22,323	0	For
ALPS ETF Trust	0	21,449	Against

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

7. TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATED

99.9% fund support · no official result

FOR 99.9%

The 48 asset managers below cast 99.9% of the shares they voted on this item FOR (14,602,934 for, 1,285 against).

FOR: 14,602,934 (100.0%)AGAINST: 1,285 (0.0%)

Largest asset managers voting on “TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS THE INDEPENDE” at MACROGENICS INC., 2024-2025
Asset manager	For	Vote
Vanguard	4,345,235	For
WASATCH FUNDS TRUST	3,576,558	For
BlackRock	2,585,492	For
Fidelity	1,356,873	For
Charles Schwab	524,282	For
Dimensional	434,316	For
Delaware/Macquarie	420,000	For
Equitable	210,850	For
TIAA	195,772	For
BRIDGEWAY FUNDS INC	125,000	For
QUANTITATIVE MASTER SERIES LLC	108,027	For
Voya	97,922	For
Lincoln Financial	52,863	For
CLEARWATER INVESTMENT TRUST	50,311	For
ETF Series Solutions	45,885	For
Nationwide	40,316	For
Columbia Threadneedle	40,225	For
American Century	37,009	For
Global X	36,499	For
Northern Trust	32,213	For
Goldman Sachs	31,208	For
Invesco	29,421	For
John Hancock	23,853	For
Pacific Life	22,323	For
ALPS ETF Trust	21,449	For

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

Largest MACROGENICS INC. shareholders voting in 2024-2025

Ranked by the number of MACROGENICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 63,090,323 shares outstanding at the time of that meeting.

Top MACROGENICS INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	ARMISTICE CAPITAL, LLC	8.70%
2	Vanguard	7.07%
3	BlackRock	7.06%
4	WASATCH ADVISORS LP	6.08%
5	WASATCH FUNDS TRUST	5.67%
6	Frazier Life Sciences Management, L.P.	5.03%
7	Fidelity	2.32%
8	GEODE CAPITAL MANAGEMENT, LLC	2.30%
9	Rock Springs Capital Management LP	1.67%
10	Charles Schwab	1.66%

Reported MACROGENICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

MACROGENICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BB Biotech AG	15.74%	DEF14A
Armistice Capital, LLC	9.95%	DEF14A
BlackRock	7.79%	13F
Vanguard Group	7.02%	13F
Wasatch Advisors LP	5.53%	DEF14A
BANK OF AMERICA CORP /DE/	5.16%	13G
Millennium Management	2.73%	13F
Geode Capital	2.31%	13F
State Street	2.23%	13F
Scott Koenig, M.D., Ph.D.	2.18%	DEF14A

Percentages above are of 63,090,323 shares outstanding, as reported by MACROGENICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MACROGENICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At MACROGENICS INC.'s shareholder meeting held 2025-05-21, in the 2024-2025 proxy season, 143 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,106 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers as… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: MACROGENICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-22.

MACROGENICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page).